| Project/Area Number |
24792195
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Surgical dentistry
|
|---|
| Research Institution | Kanazawa University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2012-04-01 – 2014-03-31
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Keywords | 口腔扁平上皮癌 / 増殖抑制 / 線維芽細胞増殖抑制剤 / シスプラチン / 血管新生阻害剤 / 浸潤 / 転移 / 血管新生阻害薬 |
|---|
| Research Abstract |
Using an orthotopic implantation mice model in which the invasion and metastasis of oral cancer can be reproduced, we investigated the inhibitory effects of anticancer agent and fibroblast growth inhibitor and antiangiogenic agent on invasion and metastasis. A highly invasive and metastatic human oral squamous cell carcinoma cell line, OLC-01, OSC-19 was implanted into the tongue of nude mice, and cisplatin or tranilast or avastin were administered to the mice after the implantation. The effects of each drug on cancer invasion and metastasis were investigated. Tumor size and stroma collagen fiber content were significantly reduced in conbination group of cisplatin and tranilast. And tumor stroma were changed charactaristic in conbination group. Lymph node matastasis and vascularization were significantly reduced in avastin group.
The use of anticancer agent and fibroblast growth inhibitor and antiangiogenic agent considering these effects may be clinically very useful.
|
